Trial Profile
A Phase I/II, Two- Staged Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts and Clinical Recovery Successfully Completed
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Apr 2023
Price :
$35
*
At a glance
- Drugs Nowarta-110 (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Nowarta Biopharma
- 25 Apr 2023 Results assessing compare the efficacy and safety of naturally derived Nowarta110 topical formula versus a matching placebo in treating plantar warts published in the Anticancer Research
- 09 Jul 2016 Primary endpoint has been changed from local adverse event and site reaction to Lesion Assessment and time frame of endpoint also changed from 7 days to 6 weeks,
- 31 Mar 2016 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.